VCP ScannerFree US Stock Screener & Financial AnalysisFree US Stock Screener
ScreenerThemesMarketEarningsCompareWatchlistInsider
MYOMyomo, Inc.
$1.28$49M
Research
Overview
Valuation
ValuationTargetsPrice
Financials
RevenueEarningsP/ERatiosDividend
Ownership
Holders
Tools
Total ReturnDCA Calculator
← Back to Screener
VCP ScannerFree US Stock Screener & Financial Analysis

Find stocks. Verify deeply. Act with conviction.

Data updated daily

Product

  • Screener
  • Themes
  • Valuation
  • Total Return
  • DCA Calculator
  • News
  • Earnings

Resources

  • Market Valuation
  • Compare
  • Insider Activity
  • Methodology
  • How It Works
  • Glossary
  • Learn

Get Ideas

Get weekly stock ideas — free

Follow VCP Scanner on XFollow VCP Scanner on LinkedIn
© 2026 VCP Scanner
AboutPrivacyTerms
Not financial advice. Do your own research.
ScreenerNewsCompareWatchlist

MYO logoMyomo, Inc.(MYO)Earnings, Financials & Key Ratios

MYO•NYSE
Price updated Jun 19, 2026
SectorHealthcareIndustryMedical DevicesSub-IndustryOrthopedics, spine, and sports medicine
AboutMyomo, Inc., a wearable medical robotics company, designs, develops, and produces myoelectric orthotics for people with neuromuscular disorders in the United States. The company offers MyoPro, a myoelectric-controlled upper limb brace or orthosis product used for supporting a patient's weak or paralyzed arm to enable and improve functional activities of daily living. Its products are designed to help improve function in adults and adolescents with neuromuscular conditions due to brachial plexus injury, stroke, traumatic brain injury, spinal cord injury, and other neurological disorders. The company sells its products to orthotics and prosthetics providers, the Veterans Health Administration, and rehabilitation hospitals, as well as through distributors. Myomo, Inc. was incorporated in 2004 and is headquartered in Boston, Massachusetts.Show more
  • Revenue$41M+25.7%
  • EBITDA-$13M-132.7%
  • Net Income-$16M-151.9%
  • EPS (Diluted)-0.37-131.3%
  • Gross Margin65.7%-7.8%
  • EBITDA Margin-30.88%-85.1%
  • Operating Margin-35.19%-84.5%
  • Net Margin-38.05%-100.3%
  • ROE-86.24%-135.0%

MYO Key Insights

Myomo, Inc. (MYO) fundamental analysis — strengths, weaknesses & financial health based on data analysis

✓Strengths

  • ✓Momentum leader: RS Rating 89 (top 11%)
  • ✓Strong 5Y sales CAGR of 40.1%
  • ✓Efficient asset utilization: 1.1x turnover

✗Weaknesses

  • ✗Weak Piotroski F-Score: 3/9
  • ✗Negative free cash flow
  • ✗Shares diluted 10.8% in last year
  • ✗Trading more than 30% below 52-week high

* These insights are generated automatically based on available financial data. Please conduct your own research before making investment decisions.

Get notified when MYO posts new earnings or crosses analyst targets

Free. No account needed. Unsubscribe any time.

Free. Unsubscribe any time.

MYO Price & Volume

Myomo, Inc. (MYO) stock price & volume — 10-year historical chart

Loading chart...

MYO Growth Metrics

Myomo, Inc. (MYO) revenue, earnings & EPS growth — 3, 5 & 10-year CAGR

Revenue CAGR

10 Years50.43%
5 Years40.1%
3 Years38.05%
TTM6.68%

Profit CAGR

10 Years-
5 Years-
3 Years-
TTM-160.07%

EPS CAGR

10 Years-
5 Years-
3 Years-
TTM-147.19%

Return on Capital

10 Years-106.71%
5 Years-70.22%
3 Years-60.48%
Last Year-46.19%

MYO Peer Comparison

Myomo, Inc. (MYO) competitors in Orthopedics, spine, and sports medicine — business model, growth, and fundamentals comparison

Select Columns
Stock Universe
Valuation
Growth
Profitability
Financial Health
Dividends & Buybacks
Price Performance
Technical
Fundamentals ($)
Sector-Specific
Institutional Holdings
CompanyMarket CapStock PriceP/E Ratio (TTM)Revenue Growth 1YNet MarginReturn on Equity (ROE)FCF YieldDebt / Equity
BFLY logoBFLYButterfly Network, Inc.Direct Competitor2.33B8.90-28.7118.96%-73.63%-36.79%0.10
ATEC logoATECAlphatec Holdings, Inc.Direct Competitor1.33B8.81-9.1824.95%-21.07%-443.09%17.21
OSUR logoOSUROraSure Technologies, Inc.Direct Competitor305.85M4.25-4.52-38.1%-61.93%-15.09%0.04
GMED logoGMEDGlobus Medical, Inc.Product Competitor10.69B79.2320.2116.65%18.92%13.04%0.03
NVCR logoNVCRNovoCure LimitedProduct Competitor1.62B14.28-11.708.28%-25.66%-50.82%0.85
LIVN logoLIVNLivaNova PLCProduct Competitor4.31B78.50-17.6410.74%7.47%9.13%0.39
SYK logoSYKStryker CorporationSupply Chain117.88B307.8036.6411.16%12.92%15.04%0.66
MDT logoMDTMedtronic plcSupply Chain101.86B79.3421.983.62%13%9.49%0.59

Compare MYO vs Peers

Myomo, Inc. (MYO) vs competitors — business, growth, and fundamentals comparison against the closest industry rivals.

Closest Rival

vs BFLY

Most directly comparable listed peer for MYO.

Scale Benchmark

vs ISRG

Larger-name benchmark to compare MYO against a more recognizable public peer.

Peer Set

Compare Top 5

vs BFLY, ATEC, OSUR, GMED

MYO Income Statement

Myomo, Inc. (MYO) annual income statement — 10-year revenue, gross profit & net income history

10Y historyFree accessUpdated daily
MetricDec'17Dec'18Dec'19Dec'20Dec'21Dec'22Dec'23Dec'24Dec'25TTM
Sales/Revenue
1.56M2.44M3.84M7.58M13.86M15.56M19.24M32.55M40.93M41.21M
Revenue Growth %
41.29%56.79%57.02%97.6%82.72%12.26%23.7%69.17%25.73%6.68%
Cost of Goods Sold
505.28K728.28K917.62K2.6M3.54M5.3M6.06M9.37M14.04M14.03M
COGS % of Revenue
32.41%29.8%23.91%34.29%25.58%34.09%31.49%28.77%34.3%-
Gross Profit
1.05M▲ 0%
1.72M▲ 62.9%
2.92M▲ 70.2%
4.98M▲ 70.6%
10.31M▲ 106.9%
10.25M▼ 0.6%
13.18M▲ 28.6%
23.19M▲ 75.9%
26.89M▲ 16.0%
27.18M▲ 0%
Gross Margin %
67.59%70.2%76.09%65.71%74.42%65.91%68.51%71.23%65.7%65.96%
Gross Profit Growth %
28.31%62.86%70.19%70.64%106.95%-0.57%28.57%75.88%15.97%-
Operating Expenses
7.6M12.24M13.72M15.49M20.58M20.93M21.41M29.39M41.29M41.22M
OpEx % of Revenue
487.64%500.97%357.38%204.21%148.53%134.52%111.29%90.29%100.88%-
Selling, General & Admin
5.85M10.41M11.55M13.82M18.02M18.44M18.78M24.62M34.35M34.44M
SG&A % of Revenue
375.27%425.74%301.08%182.19%130.07%118.56%97.59%75.63%83.92%-
Research & Development
1.75M1.84M2.16M1.67M2.56M2.48M2.64M4.77M6.94M6.78M
R&D % of Revenue
112.37%75.23%56.3%22.01%18.46%15.96%13.7%14.66%16.97%-
Other Operating Expenses
0000-16.95K-1.1K0000
Operating Income
-6.55M▲ 0%
-10.53M▼ 60.8%
-10.8M▼ 2.5%
-10.5M▲ 2.7%
-10.27M▲ 2.2%
-10.67M▼ 3.9%
-8.23M▲ 22.9%
-6.21M▲ 24.6%
-14.4M▼ 132.0%
-14.04M▲ 0%
Operating Margin %
-420.06%-430.77%-281.29%-138.5%-74.1%-68.61%-42.78%-19.07%-35.19%-34.07%
Operating Income Growth %
-99.94%-60.79%-2.53%2.71%2.23%-3.94%22.87%24.6%-132.04%-
EBITDA
-6.54M-10.46M-10.7M-10.39M-9.93M-10.13M-7.71M-5.43M-12.64M-12.72M
EBITDA Margin %
-419.32%-427.92%-278.81%-137.06%-71.68%-65.12%-40.09%-16.68%-30.88%-30.87%
EBITDA Growth %
-100.07%-60%-2.31%2.86%4.44%-1.99%23.85%29.61%-132.74%-170.54%
D&A (Non-Cash Add-back)
11.41K69.68K95.12K108.67K335.96K542.63K517.68K776.97K1.76M1.32M
EBIT
-6.55M-10.53M-10.8M-11.09M-10.27M-10.67M-8.23M-5.82M-14.4M-14.04M
Net Interest Income
-5.53M175.41K-113.63K-474.71K1.61K88.73K410.27K388.59K-450.83K-1.15M
Interest Income
00-01.61K88.73K410.27K388.59K476.97K106.55K
Interest Expense
358.92K358.92K113.63K474.71K0000927.8K1.25M
Other Income/Expense
-5.55M211.68K81.99K-1.06M-15.34K21.12K239.99K388.59K-667.5K-525.13K
Pretax Income
-12.1M▲ 0%
-10.32M▲ 14.7%
-10.71M▼ 3.8%
-11.56M▼ 7.9%
-10.28M▲ 11.1%
-10.65M▼ 3.6%
-7.99M▲ 25.0%
-5.82M▲ 27.2%
-15.07M▼ 159.0%
-14.56M▲ 0%
Pretax Margin %
-776.04%-422.11%-279.15%-152.49%-74.21%-68.47%-41.53%-17.87%-36.82%-35.34%
Income Tax
000088.93K69.94K156K365.62K504.53K554.45K
Effective Tax Rate %
0%0%0%0%-0.86%-0.66%-1.95%-6.28%-3.35%-3.81%
Net Income
-12.1M▲ 0%
-10.32M▲ 14.7%
-10.71M▼ 3.8%
-11.56M▼ 7.9%
-10.37M▲ 10.3%
-10.72M▼ 3.4%
-8.15M▲ 24.0%
-6.18M▲ 24.1%
-15.57M▼ 151.9%
-15.12M▲ 0%
Net Margin %
-776.04%-422.11%-279.15%-152.49%-74.86%-68.92%-42.34%-19%-38.05%-36.69%
Net Income Growth %
-234.46%14.72%-3.84%-7.94%10.3%-3.36%24%24.1%-151.85%-160.07%
Net Income (Continuing)
-12.1M-10.32M-10.71M-11.56M-10.37M-10.72M-8.15M-6.18M-15.57M-15.12M
Discontinued Operations
0000000000
Minority Interest
0000000000
EPS (Diluted)
-84.05▲ 0%
-25.15▲ 70.1%
-19.20▲ 23.7%
-3.62▲ 81.1%
-1.78▲ 50.8%
-1.52▲ 14.6%
-0.28▲ 81.6%
-0.16▲ 42.9%
-0.37▼ 131.3%
-0.36▲ 0%
EPS Growth %
-14908.93%70.08%23.66%81.15%50.83%14.61%81.58%42.86%-131.25%-147.19%
EPS (Basic)
-84.05-25.18-19.20-3.62-1.78-1.52-0.28-0.16-0.37-
Diluted Shares Outstanding
143.93K410.15K553.79K3.33M5.83M7.05M29.5M37.76M41.86M42.27M
Basic Shares Outstanding
143.93K409.75K553.79K3.33M5.83M7.05M29.1M37.76M41.86M42.27M
Dividend Payout Ratio
----------

MYO Balance Sheet

Myomo, Inc. (MYO) balance sheet — assets, liabilities & shareholders' equity

MetricDec'17Dec'18Dec'19Dec'20Dec'21Dec'22Dec'23Dec'24Dec'25TTM
Total Current Assets
13.85M7.87M6.15M14.45M19.09M9.22M13.65M32.79M27.56M25.66M
Cash & Short-Term Investments
12.96M6.54M4.47M12.24M15.52M5.35M8.87M24.87M18.39M15.7M
Cash Only
12.96M6.54M4.47M12.24M15.52M5.35M6.87M24.37M14.13M11.4M
Short-Term Investments
0000001.99M492.99K4.26M4.3M
Accounts Receivable
297.04K382.26K424.29K924.92K1.96M1.9M2.38M3.83M4.1M4.82M
Days Sales Outstanding
69.5557.0940.3544.5251.6344.4945.242.8936.5347.09
Inventory
201.16K256.15K439.53K707.11K808.31K1.4M1.8M3.17M3.12M3.55M
Days Inventory Outstanding
145.31128.38174.8399.2583.2596.37108.65123.3881.1993.94
Other Current Assets
00820.21K0-95.33K573.46K598.85K933.38K1.94M1.59M
Total Non-Current Assets
129.15K407.1K449.21K263.81K1M946.55K930.59K9.45M11.08M11.1M
Property, Plant & Equipment
77.15K187.51K154.97K263.81K908.2K703.03K839.35K8.91M6.68M6.5M
Fixed Asset Turnover
20.21x13.03x24.76x28.75x15.26x22.13x22.92x3.65x6.13x5.49x
Goodwill
0000000000
Intangible Assets
000000001.59M1.76M
Long-Term Investments
52K75K75K00132.49K000375K
Other Non-Current Assets
0144.58K219.24K095.33K111.03K91.24K539.41K2.81M2.84M
Total Assets
13.97M▲ 0%
8.28M▼ 40.7%
6.6M▼ 20.3%
14.71M▲ 122.9%
20.1M▲ 36.6%
10.16M▼ 49.4%
14.58M▲ 43.5%
42.24M▲ 189.7%
38.64M▼ 8.5%
36.75M▲ 0%
Asset Turnover
0.11x0.30x0.58x0.52x0.69x1.53x1.32x0.77x1.06x1.11x
Asset Growth %
742.75%-40.74%-20.32%122.92%36.61%-49.43%43.49%189.71%-8.54%229.15%
Total Current Liabilities
1.49M1.86M3.88M2.87M4.28M3.6M5.48M10.17M8.35M9.39M
Accounts Payable
264.89K426.73K450.1K180.5K723.35K569.68K1.07M1.17M1.51M1.81M
Days Payables Outstanding
191.35213.87179.0425.3474.539.2264.6745.5939.248.52
Short-Term Debt
001.76M00000494.66K594.94K
Deferred Revenue (Current)
168.01K108.6K2.95K2.81K192.75K773.88K8.51K2.28M218.22K2.67M
Other Current Liabilities
409.85K292.6K779.88K2.08M2.48M1.19M3.41M5.14M5.31M5.93M
Current Ratio
9.32x4.24x1.58x5.03x4.46x2.56x2.49x3.22x3.30x2.73x
Quick Ratio
9.19x4.11x1.47x4.79x4.27x2.17x2.16x2.91x2.93x2.36x
Cash Conversion Cycle
23.51-28.436.15118.4460.38101.6489.18120.6878.5392.51
Total Non-Current Liabilities
44.04K535.33K890.46K274.7K402.87K200.71K115.16K7.36M18.89M18.37M
Long-Term Debt
00888.96K0000011.22M10.93M
Capital Lease Obligations
000155.15K401.62K200.21K115.16K7.36M7.67M30.91M
Deferred Tax Liabilities
00-1.5K0000000
Other Non-Current Liabilities
001.5K118.06K000000
Total Liabilities
1.53M1.86M4.77M3.14M4.69M3.8M5.59M17.53M27.23M27.75M
Total Debt
002.65M173.44K735K553.91K601.3K8.11M19.38M18.96M
Net Debt
-12.96M-6.54M-1.81M-12.07M-14.79M-4.79M-6.27M-16.27M5.25M7.57M
Debt / Equity
--1.45x0.01x0.05x0.09x0.07x0.33x1.70x2.11x
Debt / EBITDA
----------1.49x
Net Debt / EBITDA
----------0.59x
Interest Coverage
-18.24x-29.33x-95.00x-23.36x-----15.52x-11.19x
Total Equity
12.45M▲ 0%
6.43M▼ 48.4%
1.82M▼ 71.6%
11.57M▲ 533.8%
15.41M▲ 33.2%
6.36M▼ 58.7%
8.99M▲ 41.4%
24.71M▲ 174.9%
11.4M▼ 53.9%
9M▲ 0%
Equity Growth %
171%-48.37%-71.6%533.82%33.23%-58.73%41.36%174.93%-53.86%27.06%
Book Value per Share
86.4715.673.293.472.640.900.300.650.270.21
Total Shareholders' Equity
12.45M6.43M1.82M11.57M15.41M6.36M8.99M24.71M11.4M9M
Common Stock
1.11K1.25K574576877752.71K3.44K3.85K3.86K
Retained Earnings
-34.97M-45.29M-56.13M-67.69M-78.06M-88.78M-96.93M-103.11M-118.69M-121.7M
Treasury Stock
-6.46K-6.46K-6.46K-6.46K-6.46K-6.46K-6.46K-6.46K-6.46K-6.46K
Accumulated OCI
-31.76K-100.12K0-12.69K-60.68K43.23K83.67K-14.41K164.52K174.88K
Minority Interest
0000000000

MYO Cash Flow Statement

Myomo, Inc. (MYO) cash flow — operating, investing & free cash flow history

MetricDec'17Dec'18Dec'19Dec'20Dec'21Dec'22Dec'23Dec'24Dec'25TTM
Cash from Operations
-6.15M-9.61M-10.34M-9.03M-9.55M-10.23M-6.17M-3.29M-14.51M-14.03M
Operating CF Margin %
-394.74%-393.04%-269.48%-119.11%-68.9%-65.79%-32.08%-10.11%-35.46%-
Operating CF Growth %
-92.13%-56.11%-7.66%12.66%-5.7%-7.18%39.68%46.7%-341.09%-501.08%
Net Income
-12.1M-10.32M-10.71M-11.56M-10.37M-10.72M-8.15M-6.18M-15.57M-15.12M
Depreciation & Amortization
11.41K69.68K95.12K108.67K335.96K542.63K517.68K776.97K1.98M1.53M
Stock-Based Compensation
279.51K814.67K907.99K614.3K1.1M1.19M1.12M874.44K2.08M1.54M
Deferred Taxes
-56.67K48.92K00000000
Other Non-Cash Items
5.2M-36.27K-81.92K959.13K-19.73K204.34K48.31K-17.37K855.86K1.3M
Working Capital Changes
505.97K-186.57K-550.01K848.91K-588.01K-1.45M293.21K1.26M-3.86M-3.29M
Change in Receivables
-182.53K-101.49K-42.03K-522.94K-1.05M47.45K-495.6K-1.56M376.97K322.98K
Change in Inventory
-161.07K-140.82K-213.56K-271.55K-118.22K-607.4K-384.78K-1.4M-662.68K-559.23K
Change in Payables
563.23K466.19K60.74K1.22M0-711.9K1.79M4.69M-2.9M-3.14M
Cash from Investing
-67K-126.87K-51.99K-45.75K-326.46K-310.79K-2.03M259.98K-7.06M-5.66M
Capital Expenditures
-67K-126.87K-51.99K-45.75K-326.46K-111.79K-145.82K-1.36M-1.74M-1.57M
CapEx % of Revenue
4.3%5.19%1.35%0.6%2.36%0.72%0.76%4.18%4.26%3.8%
Acquisitions
00000-199K0000
Investments
----------
Other Investing
0-126.87K000-199K00-1.59M-1.59M
Cash from Financing
18.38M3.34M8.32M16.78M13.17M376.86K9.71M20.93M11.43M11.46M
Debt Issued (Net)
554.1K02.79M-1.96M000011.43M11.43M
Equity Issued (Net)
17.7M05.6M18.55M1.1M376.86K9.72M20.37M00
Dividends Paid
0000000000
Share Repurchases
0-74.21K00000000
Other Financing
129.61K3.34M-73.38K185.3K12.07M0-8.12K563.64K036.51K
Net Change in Cash
12.16M▲ 0%
-6.4M▼ 152.6%
-2.08M▲ 67.6%
7.7M▲ 471.1%
3.28M▼ 57.4%
-10.18M▼ 410.0%
1.53M▲ 115.0%
17.88M▲ 1071.9%
-10.04M▼ 156.2%
-8.4M▲ 0%
Free Cash Flow
-6.22M▲ 0%
-9.73M▼ 56.5%
-10.39M▼ 6.8%
-9.08M▲ 12.7%
-9.87M▼ 8.8%
-10.35M▼ 4.8%
-6.32M▲ 38.9%
-4.65M▲ 26.4%
-16.25M▼ 249.5%
-17.34M▲ 0%
FCF Margin %
-399.03%-398.23%-270.83%-119.72%-71.26%-66.51%-32.84%-14.29%-39.71%-42.08%
FCF Growth %
-94.11%-56.47%-6.79%12.65%-8.76%-4.77%38.92%26.41%-249.54%-269.56%
FCF per Share
-43.22-23.73-18.77-2.73-1.69-1.47-0.21-0.12-0.39-0.41
FCF Conversion (FCF/Net Income)
0.51x0.93x0.97x0.78x0.92x0.95x0.76x0.53x0.93x1.15x
Interest Paid
00000000111.86K0
Taxes Paid
00000000330.94K0

MYO Key Ratios

Myomo, Inc. (MYO) financial ratios — P/E, ROE, debt and 30+ core market and balance-sheet ratios

Metric201720182019202020212022202320242025TTM
Return on Equity (ROE)
-97.2%-109.34%-259.69%-172.72%-76.9%-98.5%-106.17%-36.7%-86.24%-114.87%
Return on Invested Capital (ROIC)
-----13129.96%-731.96%-288.04%-83.37%-86.06%-66.43%
Gross Margin
67.59%70.2%76.09%65.71%74.42%65.91%68.51%71.23%65.7%65.96%
Net Margin
-776.04%-422.11%-279.15%-152.49%-74.86%-68.92%-42.34%-19%-38.05%-36.69%
Debt / Equity
--1.45x0.01x0.05x0.09x0.07x0.33x1.70x2.11x
Interest Coverage
-18.24x-29.33x-95.00x-23.36x-----15.52x-11.19x
FCF Conversion
0.51x0.93x0.97x0.78x0.92x0.95x0.76x0.53x0.93x1.15x
Revenue Growth
41.29%56.79%57.02%97.6%82.72%12.26%23.7%69.17%25.73%6.68%
Related:MYO Dividend History·MYO Revenue History·MYO Price History·MYO P/E History·MYO Financial Ratios·MYO Institutional Holders

MYO SEC Filings & Documents

Myomo, Inc. (MYO) SEC filings — annual & quarterly reports (10-K, 10-Q)

8-K Announcements

6
Material company update

May 13, 2026·SEC

Material company update

May 7, 2026·SEC

Material company update

Apr 16, 2026·SEC

10-K Annual Reports

3
FY 2026

Mar 9, 2026·SEC

FY 2025

Mar 10, 2025·SEC

FY 2024

Mar 8, 2024·SEC

10-Q Quarterly Reports

6
FY 2026

May 7, 2026·SEC

FY 2025

Nov 10, 2025·SEC

FY 2025

Aug 11, 2025·SEC

MYO Frequently Asked Questions

Myomo, Inc. (MYO) stock FAQ — growth, dividends, profitability & financials explained

Growth & Financials

Myomo, Inc. (MYO) reported $41.2M in revenue for fiscal year 2025. This represents a 4412% increase from $0.9M in 2014.

Myomo, Inc. (MYO) grew revenue by 25.7% over the past year. This is strong growth.

Myomo, Inc. (MYO) reported a net loss of $15.1M for fiscal year 2025.

Dividend & Returns

Myomo, Inc. (MYO) has a return on equity (ROE) of -86.2%. Negative ROE indicates the company is unprofitable.

Myomo, Inc. (MYO) had negative free cash flow of $17.3M in fiscal year 2025, likely due to heavy capital investments.

What if you invested $1,000 in MYO back in 2014?

Total return calculator · dividends reinvested · 12+ years of data

See returns →

How much would $100/month in MYO be worth today?

Dollar cost averaging calculator · DCA vs lump sum

Calculate →